Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 430-500-8 | CAS number: 204277-61-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 26 October 1998 to 3 December 1998.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP methodology followed and OCED guideline 406 used to performed the experiment.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1999
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- Principles of method if other than guideline:
- None
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- -
- EC Number:
- 430-500-8
- EC Name:
- -
- Cas Number:
- 204277-61-2
- Molecular formula:
- Hill formula: C23 H23 Cl N6 O8 CAS formula: C23 H23 Cl N6 O8
- IUPAC Name:
- methyl 2-({4-[2-(2-chloro-6-cyano-4-nitrophenyl)diazen-1-yl]-5-acetamido-2-methoxyphenyl}(2-methoxy-2-oxoethyl)amino)propanoate
- Details on test material:
- None
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Ibm: GOHI; SPF-quality guinea pigs (synonym: Himalayan spotted).
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd, Biotechnology & Animal Breeding Division, Wölferstrasse 4, CH-4414 Füllinsdorf / Switzerland
- Age at delivery: 4 - 6 weeks
- Age at study initiation: 4 - 6 weeks
- Body weight at pretest start: Pretest groups: 332 - 342 g
- Body weight at beginning of acclimatization period: Control and test group 332 - 430 g
- Housing: Individually in Makrolon type-4 cages with standard softwood bedding ("Lignocel", Schill AG, CH-4132 Muttenz).
- Diet: Pelleted standard Nafag Ecosan 845 25W4, batch no. 76/98 guinea pig breeding / maintenance diet ("Nafag", Nähr- und Futtermittel AG, CH-9202 Gossau), ad libitum.
- Water : Community tap water from Füllinsdorf, ad libitum.
- Acclimation period: One week for the control and test group under test conditions after health examination. No acclimatization for the animals of the pretest. Only animals without any visible signs of illness were used.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-23 °C
- Humidity (%): relative humidity between 33-68 %
- Air changes (per hr): Air-conditioned with 10-15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12-hour light, 12-hour dark cycle. Music was played during the light period.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 400
- Concentration / amount:
- - In the pre-test (Intredermal injection)during the acclimatization period of the control and test group: 5% / 3% / 1%
(According to Magnusson - Kligman and to the findings observed, the concentration selected for the main study was 5 %)
- In the pre-test (Epidermal injection)during the acclimatization period of the control and test group:10% / 15% / 25% / 30%.
According to Magnusson - Kligman and to the findings observed, the test article at 30 % was considered to be the maximally tolerated
concentration to stimulate a state of immune hypersensitivity and the highest non-irritating concentration to be used for the challenge.
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 400
- Concentration / amount:
- - In the pre-test (Intredermal injection)during the acclimatization period of the control and test group: 5% / 3% / 1%
(According to Magnusson - Kligman and to the findings observed, the concentration selected for the main study was 5 %)
- In the pre-test (Epidermal injection)during the acclimatization period of the control and test group:10% / 15% / 25% / 30%.
According to Magnusson - Kligman and to the findings observed, the test article at 30 % was considered to be the maximally tolerated
concentration to stimulate a state of immune hypersensitivity and the highest non-irritating concentration to be used for the challenge.
- No. of animals per dose:
- - Control group: 5 animals
- Test group: 10 animals
- Intradermal pretest: 1 animal
- Epidermal pretest: 2 animals - Details on study design:
- PRETEST (performed during the acclimatization period of the control and test group):
- Intradermal injections:
Four intradermal injections (0.1 ml/site) of a 1:1 (v/v) mixture of Freund's Complete Adjuvant/physiological saline were made into the shaved neck
of one guinea pig. One week later intradermal injections (0.1 ml/site) were made into the clipped flank of the same guinea pig at concentrations of 5, 3 and 1 % of the test article in PEG 400. The resulting dermal reactions were assessed 24 hours later
- Epidermal applications: Four intradermal injections (0.1 ml/site) of a 1:1 (v/v) mixture of Freund's Complete
Adjuvant/physiological saline were made. One week later both flanks of each of the guinea pigs were clipped and shaved just prior to the
application. Thereafter 4 patches of filter paper were saturated with the test article at A = 30 % (this concentration was found to be the most qualified to assure an optimum technical application procedure), B= 25%, C= 15% and D= 10% and applied to the clipped and shaved flanks. The amount of test article applied was approximately 0.2 g for the test article at 30 % and 25 % and a volume of 0.2 ml for the remaining test article concentrations.
The dressings were removed after an exposure period of 24 hours.
Approximately 21 hours after removal of the dressing the application site was depilated with an approved depilatory cream (VEET Cream, Reckitt & Colman AG, CH-4123 Allschwil) to clean the application site from black staining produced by the test article, so that possible erythema reactions were clearly visible at that time.
MAIN STUDY (INDUCTION):
INTRADERMAL INJECTIONS / PERFORMED ON TEST DAY 1:
An area of dorsal skin from the scapular region (approximately 6 x 8 cm) was clipped free of hair. Three pairs of intradermal injections (0.1 ml/site) were made at the border of a 4 x 6 cm area in the clipped region as follows:
Test group:
1) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
2) The test article, at 5 % in PEG 400.
3) The test article at 5 % in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
Control group:
1) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
2) PEG 400
3) 1:1 (w/w) mixture of PEG 400 in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
EPIDERMAL APPLICATIONS/PERFORMED ON TEST DAY 8:
On test day 7 and approximately 22.5 hours prior to the epidermal application the scapular area (approximately 6 x 8 cm) of the animals of the control and test group was clipped, shaved free of hair and the test area was pretreated with a 10 % dilution of Sodium-Lauryl-Sulfate (SLS) in paraffinum perliquidum as no primary irritation had been observed in the pretest. The SLS was massaged into the skin with a glass rod without bandaging. This 10 % concentration of SLS enhances sensitization by provoking a mild inflammatory reaction (Magnusson and Kligman 1970).
On test day 8, a patch of filter paper was saturated with the test article (30 % in PEG 400) and placed over the injection sites of the test animals. The amount of test article applied was approximately 0.3 g. The patch was covered with aluminum foil and firmly secured by an elastic plaster wrapped around the trunk of the animal and secured with impervious adhesive tape. The dressings were left in place for 48 hours.
The guinea pigs of the control group were treated as described above with PEG 400 only, applied at a volume of approximately 0.3 ml.
Reaction sites were assessed for erythema and oedema 24 and 48 hours after removal of the dressing, using the numerical grading system
according to Draize. - Challenge controls:
- CHALLENGE / PERFORMED ON TEST DAY 22:
The test and control guinea pigs were challenged two weeks after the epidermal induction application. The test and control guinea pigs were trea
ted in the same way.
Hair was clipped and shaved on the left and right flank of each guinea pig just prior to the application. Two patches ( 3 x 3 cm) of filter paper were saturated with the highest non-irritating concentration of 30 % (left flank) and the vehicle only (PEG 400 applied to the right flank) using the same method as for the epidermal application. The amount of test article applied was approximately 0.2 g and a volume of 0.2 ml was used for the vehi
cle. The dressings were left in place for 24 hours.
Approximately 21 hours after removal of the dressing the test sites treated with the test article were depilated as described in the epidermal pretest.
Approximately 24 and 48 hours after the removal of the dressing the application sites were assessed for erythema and oedema using the numerical scoring system according to Draize. - Positive control substance(s):
- no
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: Control group (FAT 41024/B)
- Dose level:
- 30% in PEG 400
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: other: Control group (FAT 41024/B). Dose level: 30% in PEG 400. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: Control group (FAT 41024/B)
- Dose level:
- 30 % in PEG 400
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: Control group (FAT 41024/B). Dose level: 30 % in PEG 400. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: Vehicle control (PEG 400 only)
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: other: Vehicle control (PEG 400 only). No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: Vehicle control (PEG 400 only)
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: Vehicle control (PEG 400 only). No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: Test group with FAT 41024/B
- Dose level:
- 30 % in PEG 400
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: other: Test group with FAT 41024/B. Dose level: 30 % in PEG 400. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: Test group with FAT 41024/B
- Dose level:
- 30 % in PEG 400
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: Test group with FAT 41024/B. Dose level: 30 % in PEG 400. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: Test group with PEG 400
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: other: Test group with PEG 400. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: Test group with PEG 400
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: other: Test group with PEG 400. No with. + reactions: 0.0. Total no. in groups: 10.0.
Any other information on results incl. tables
Main Study:
SKIN EFFECTS AFTER INTRADERMAL INDUCTION - PERFORMED ON TEST DAY 1
The expected and common findings were observed in the control and test group after the different applications using FCA intradermally. The intradermal applications were observed with erythema, oedema, necrotizing dermatitis, encrustation and exfoliation of encrustation.
SKIN EFFECTS AFTER EPIDERMAL INDUCTION - PERFORMED ON TEST DAY 8
- CONTROL GROUP: No erythematous or oedematous reaction was observed in the animals treated with PEG 400 only.
- TEST GROUP: As the test article stained the skin black, it was not possible to determine whether erythema was present or not after treatment with the test article at 30 % in PEG 400. However, no oedema was observed.
All animals of the control and test group were pretreated with 10 % SLS in paraffinum perliquidum.
SKIN EFFECTS AFTER THE CHALLENGE - PERFORMED ON TEST DAY 22
- CONTROL GROUP: No skin reactions were observed in the animals either when treated with PEG 400 only or when treated with the test article at 30 % in PEG 400.
Black discoloration was noted directly after removal of the patch. To remove discoloration all animals were depilated approximately 3 hours prior to challenge reading.
- TEST GROUP: No skin reactions were observed in the animals either when treated with PEG 400 only or when treated with the test article at 30 % in PEG 400.
Black discoloration was noted directly after removal of the patch. To remove discoloration all animals were depilated approximately 3 hours prior to challenge reading.
VIABILITY / MORTALITY / MACROSCOPIC FINDINGS
As there were no deaths during the course of the treatment period no necropsies were performed.
CLINICAL SIGNS, SYSTEMIC
No symptoms of systemic toxicity were observed in the animals.
BODY WEIGHTS
One animal of the test group showed a weak loss of body weight (2 %) during the treatment period. The body weight of the other animals was within the range commonly recorded for animals of this strain and age.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Migrated information
- Conclusions:
- FAT41024/B applied at a concentration of 30 % in PEG 400 is considered not to be a sensitizer when used under the described test conditions.
- Executive summary:
In order to assess the cutaneous allergenic potential of FAT 41024/B, the Maximization-Test was performed in 15 (10 test and 5 control) female albino guinea pigs, in accordance with OECD Guideline No. 406 and the Directive 96/54/EEC, B.6.
The intradermal induction of sensitization was performed with a 5 % dilution of the test article in polyethylene glycol (PEG 400) and in an emulsion of Freund's Complete Adjuvant (FCA) / physiological saline. The epidermal induction of sensitization was conducted under
occlusion with the test article at 30 % in PEG 400. Two weeks after the epidermal induction application the challenge was completed by epidermal application of the test article at 30 % in PEG 400 under occlusive dressing. The animals of the control group were induced with PEG 400 and FCA/physiological saline and challenged similarly to those of the test group. Cutaneous reactions, i.e. erythema and eschar, as well as oedema formation were evaluated at 24 and 48 hours after removal of the dressing.
ERYTHEMATOUS REACTIONS AFTER THE CHALLENGE PROCEDURE
After 24 hours
After 48 hours
(Positive/total) / (% positive of total) (Positive/total) / (% positive of total) Control group: FAT 41024/B (left flank) (0/5) / 0 (0/5) / 0 Control group: PEG only (right flank) (0/5) / 0
(0/5) / 0Test group: FAT 41024/B (left flank) (0/5) / 0 (0/5) / 0 Test group: PEG 400 (right flank) (0/5) / 0 (0/5) / 0 No toxic symptoms were evident in the guinea pigs of the control or test group.
No deaths occured.
Conclusion:
In this study none of the animals of the test group were observed with erythematous reactions after treatment with a non-irritant test article concentration of 30 % in PEG 400. No skin reactions were observed in the control group.
Therefore, the test article FAT41024/B applied at a concentration of 30 % in PEG 400 is considered not to be a sensitizer when used under the described test conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.